Your browser doesn't support javascript.
loading
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
Nikitin, Eugene; Kislova, Maria; Morozov, Dmitry; Belyakova, Vera; Suvorova, Anna; Sveshnikova, Julia; Vyscub, Galina; Matveeva, Irina; Shirokova, Maria; Shipaeva, Anna; Klitochenko, Tatyana; Makarovskaya, Polina; Dmitrieva, Elena; Biderman, Bella; Sudarikov, Andrei; Obukhova, Tatyana; Samoilova, Olga; Kaplanov, Kamil; Konstantinova, Tatyana; Mayorova, Olga; Poddubnaya, Irina; Ptushkin, Vadim.
Afiliação
  • Nikitin E; State Budgetary Healthcare Institution of the city of Moscow City Clinical Hospital named after S.P. Botkin of Moscow City Healthcare Department, Moscow, Russian Federation. eugene_nikitin@mail.ru.
  • Kislova M; Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation. eugene_nikitin@mail.ru.
  • Morozov D; State Budgetary Healthcare Institution of the city of Moscow City Clinical Hospital named after S.P. Botkin of Moscow City Healthcare Department, Moscow, Russian Federation.
  • Belyakova V; State Budgetary Health Institution of the Nizhny Novgorod Region "Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko", Nizhny, Novgorod, Russian Federation.
  • Suvorova A; State Budgetary Healthcare Institution of the city of Moscow Blood Center named after O.K. Gavrilov of the Moscow City Healthcare Department, Moscow, Russian Federation.
  • Sveshnikova J; State Budgetary Health Institution of the Nizhny Novgorod Region "Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko", Nizhny, Novgorod, Russian Federation.
  • Vyscub G; State Autonomous Healthcare Institution of the Sverdlovsk Region "Sverdlovsk Regional Clinical Hospital N 1", Ekaterinburg, Russian Federation.
  • Matveeva I; State Budgetary Health Institution "Volgograd Regional Clinical Oncology Center", Volgograd, Russian Federation.
  • Shirokova M; State Budgetary Health Institution "Volgograd Regional Clinical Oncology Center", Volgograd, Russian Federation.
  • Shipaeva A; State Budgetary Healthcare Institution of the city of Moscow City Clinical Hospital named after S.P. Botkin of Moscow City Healthcare Department, Moscow, Russian Federation.
  • Klitochenko T; State Budgetary Health Institution "Volgograd Regional Clinical Oncology Center", Volgograd, Russian Federation.
  • Makarovskaya P; State Budgetary Health Institution "Volgograd Regional Clinical Oncology Center", Volgograd, Russian Federation.
  • Dmitrieva E; State Budgetary Health Institution of the Nizhny Novgorod Region "Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko", Nizhny, Novgorod, Russian Federation.
  • Biderman B; State Budgetary Healthcare Institution of the city of Moscow City Clinical Hospital named after S.P. Botkin of Moscow City Healthcare Department, Moscow, Russian Federation.
  • Sudarikov A; National Medical Research Center for Hematology, Moscow, Russian Federation.
  • Obukhova T; National Medical Research Center for Hematology, Moscow, Russian Federation.
  • Samoilova O; National Medical Research Center for Hematology, Moscow, Russian Federation.
  • Kaplanov K; State Budgetary Health Institution of the Nizhny Novgorod Region "Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko", Nizhny, Novgorod, Russian Federation.
  • Konstantinova T; State Budgetary Healthcare Institution of the city of Moscow City Clinical Hospital named after S.P. Botkin of Moscow City Healthcare Department, Moscow, Russian Federation.
  • Mayorova O; State Autonomous Healthcare Institution of the Sverdlovsk Region "Sverdlovsk Regional Clinical Hospital N 1", Ekaterinburg, Russian Federation.
  • Poddubnaya I; State Budgetary Healthcare Institution of the city of Moscow Blood Center named after O.K. Gavrilov of the Moscow City Healthcare Department, Moscow, Russian Federation.
  • Ptushkin V; Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation.
Leukemia ; 37(7): 1464-1473, 2023 07.
Article em En | MEDLINE | ID: mdl-37202442
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Leucemia Linfocítica Crônica de Células B / Aplasia Pura de Série Vermelha / Anemia Hemolítica Autoimune Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Leucemia Linfocítica Crônica de Células B / Aplasia Pura de Série Vermelha / Anemia Hemolítica Autoimune Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article